Patrik Jonsson

Patrik Jonsson is the President of Lilly Cardiometabolic Health at Eli Lilly & Company, where he advocates for the recognition of obesity as a chronic disease and has been instrumental in the company's initiatives to enhance the affordability and accessibility of weight-loss medications like Zepbound.